Search results for "Therapeutics."

showing 10 items of 480 documents

Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis

2022

Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by an abnormal reepithelialisation, an excessive tissue remodelling and a progressive fibrosis within the alveolar wall that are not due to infection or cancer. Oxidative stress has been proposed as a key molecular process in pulmonary fibrosis development and different components of the redox system are altered in the cellular actors participating in lung fibrosis. To this respect, several activators of the antioxidant machinery and inhibitors of the oxidant species and pathways have been assayed in preclinicalin vitroandin vivomodels and in different clinical trials. This review discusses the role of …

PharmacologyIPF—idiopathic pulmonary fibrosisantioxidant therapyfibrosisoxidative stressPharmacology (medical)Therapeutics. PharmacologyRM1-950Reviewrespiratory systemROS—reactive oxygen speciesrespiratory tract diseasesFrontiers in Pharmacology
researchProduct

Evaluation of the IKKβ Binding of Indicaxanthin by Induced-Fit Docking, Binding Pose Metadynamics, and Molecular Dynamics

2021

Background: Indicaxanthin, a betaxanthin belonging to the betalain class of compounds, has been recently demonstrated to exert significant antiproliferative effects inducing apoptosis of human melanoma cells through the inhibition of NF-κB as the predominant pathway. Specifically, Indicaxanthin inhibited IκBα degradation in A375 cells. In resting cells, NF-κB is arrested in the cytoplasm by binding to its inhibitor protein IκBα. Upon stimulation, IκBα is phosphorylated by the IKK complex, and degraded by the proteasome, liberating free NF-κB into the nucleus to initiate target gene transcription. Inhibition of the IKK complex leads to the arrest of the NF-κB pathway.Methods: To acquire deta…

PharmacologyMolecular modelChemistryAllosteric regulationIKKβMetadynamicsindicaxanthinInhibitor proteinRM1-950Settore CHIM/08 - Chimica Farmaceuticamolecular dynamicsIκBαchemistry.chemical_compoundanticancer activityProteasomeDocking (molecular)Settore BIO/10 - BiochimicaBiophysicsbinding pose metadynamicsPharmacology (medical)induced fit dockingTherapeutics. PharmacologyIndicaxanthinOriginal ResearchFrontiers in Pharmacology
researchProduct

COVID-19 and Periodontitis: A Dangerous Association?

2022

PharmacologyOpinionperiodontal infectionSARS-CoV-2periodontal diseaseCOVID-19Pharmacology (medical)Therapeutics. PharmacologyRM1-950periodontitisFrontiers in Pharmacology
researchProduct

Physicochemical stability of human insulin 1 I.U./mL infusion solution in 50 mL polypropylene syringes

2021

Abstract Objectives The objective of this study was to investigate the physicochemical stability of human insulin 1 I.U./mL injection solutions (Insuman® Rapid) diluted with 0.9% NaCl solution in 50 mL disposable three-piece polypropylene syringes and stored refrigerated or at room temperature. Methods 1 I.U./mL test solutions were prepared with Insuman® Rapid and 0.9% sodium chloride infusion solution in 50 mL Original-Perfusor® syringes and BD® Perfusion syringes. Test solutions were stored for 90 days at 2–8 °C/dark or 48 h at 20–25 °C/diffuse room light in order to determine chemical stability. Additional test solutions were stored 28 days at 2–8 °C/dark followed by 24 h at 20–25 °C/dif…

PharmacologyPolypropyleneChromatographyInternational unitphysicochemical stabilityInfusion solutionPharmacyRM1-950polypropylene syringechemistry.chemical_compoundchemistryHuman insulinhuman insulinPharmacology (medical)intravenous injectionTherapeutics. PharmacologyHD9665-9675Pharmaceutical industryPharmaceutical Technology in Hospital Pharmacy
researchProduct

Cameroonian Medicinal Plants: Pharmacology and Derived Natural Products

2010

Many developing countries including Cameroon have mortality patterns that reflect high levels of infectious diseases and the risk of death during pregnancy and childbirth, in addition to cancers, cardiovascular diseases and chronic respiratory diseases that account for most deaths in the developed world. Several medicinal plants are used traditionally for their treatment. In this review, plants used in Cameroonian traditional medicine with evidence for the activities of their crude extracts and/or derived products have been discussed. A considerable number of plant extracts and isolated compounds possess significant antimicrobial, anti-parasitic including antimalarial, anti-proliferative, a…

PharmacologyTraditional medicineDrug discoverybusiness.industryethnophamacologylcsh:RM1-950Review ArticleAntimicrobialTerpenoidlcsh:Therapeutics. PharmacologyAfricaMedicineRather poorPharmacology (medical)Risk of deathethnopharmacologyMedicinal plantsbusinessmedicinal plantsFrontiers in Pharmacology
researchProduct

Fatal Tumour Lysis Syndrome Induced by Brigatinib in a Lung Adenocarcinoma Patient Treated With Sequential ALK Inhibitors: A Case Report

2021

Tumour lysis syndrome (TLS) represents a group of fatal metabolic derangements resulting from the rapid breakdown of tumour cells. TLS typically occurs soon after the administration of chemotherapy in haematologic malignancies but is rarely observed in solid tumours. Here, we report a case of brigatinib-induced TLS after treatment with sequential anaplastic lymphoma kinase (ALK) inhibitors in a patient with advanced ALK-rearranged lung adenocarcinoma. The patient was treated sequentially with crizotinib, alectinib, and ensartinib. High-throughput molecular profiling after disease progression indicated that brigatinib may overcome ALK resistance mutations, so the patient was administered bri…

Pharmacologybrigatinibacute kidney injurycase reportPharmacology (medical)Therapeutics. PharmacologyRM1-950targeted therapynon-small cell lung cancertumour lysis syndromeFrontiers in Pharmacology
researchProduct

European Databases on Stability and Compatibility of Injectable Medicinal Products in Europe

2020

AbstractIn hospitals, the majority of medication therapy is administered intravenously. Especially, in intensive care units, simultaneous of various injectable drugs is a common practice Drug incompatibilities have been reported to be associated with up to 60 % of all serious and life-threatening adverse drug events. Several databases are used by hospital pharmacists to answer the questions of (in)compatibility of co-administered injectable drugs. The objective of this article is to present the European databases on compatibility and stability of injectable drugs. According to a questionnaire which was sent to the National Hospital Pharmacy Associations of the 28 countries of European Commu…

Pharmacologybusiness.industryelectronic databasePharmacyRM1-950compatibility030226 pharmacology & pharmacyBiotechnologychemical stability03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisCompatibility (mechanics)MedicinePharmacology (medical)Electronic databaseTherapeutics. PharmacologyHD9665-9675businessinjectable drugsPharmaceutical industryPharmaceutical Technology in Hospital Pharmacy
researchProduct

Cinnamomum Species: Bridging Phytochemistry Knowledge, Pharmacological Properties and Toxicological Safety for Health Benefits

2021

The genus Cinnamomum includes a number of plant species largely used as food, food additives and spices for a long time. Different traditional healing systems have used these plants as herbal remedies to cure diverse ailments. The aim of this comprehensive and updated review is to summarize the biodiversity of the genus Cinnamomum, its bioactive compounds, the mechanisms that underlie the pharmacological activities and molecular targets and toxicological safety. All the data in this review have been collected from databases and recent scientific literature including Web of Science, PubMed, ScienceDirect etc. The results showed that the bioactive compounds of Cinnamomum species possess antim…

Pharmacologyclinical trialsPhytochemistryPhytochemistryTraditional medicineWeb of scienceRM1-950ReviewHealth benefitsBiologybiology.organism_classificationmechanisms of actionClinical trialsMechanisms of actionPlant speciesMolecular targetsphytochemistryPharmacology (medical)Toxicological dataTherapeutics. PharmacologyCinnamomumCiannamomum spp.
researchProduct

Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs

2020

Pharmacologydrug-designmedicine.medical_specialty2019-20 coronavirus outbreakdrug-design; efficacy/risk ratio; innovative therapies; pharmaceutical innovations; pharmacology innovationCoronavirus disease 2019 (COVID-19)business.industrypharmacology innovationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:RM1-950lcsh:Therapeutics. PharmacologyInnovative Therapiesinnovative therapiespharmaceutical innovationsmedicinePharmacology (medical)Intensive care medicinebusinessPharmaceutical innovationsefficacy/risk ratio
researchProduct

A Symphytum officinale Root Extract Exerts Anti-inflammatory Properties by Affecting Two Distinct Steps of NF-κB Signaling

2019

Symphytum officinale, commonly known as comfrey, constitutes a traditional medicinal plant with a long-standing therapeutic history, and preparations thereof have been widely used for the treatment of painful muscle and joint complaints, wound and bone healing, and inflammation. Today, its topical use is based on its analgesic and anti-inflammatory effects, which have been substantiated by modern clinical trials. However, the molecular basis of its action remained elusive. Here, we show that a hydroalcoholic extract of comfrey root impairs the development of a pro-inflammatory scenario in primary human endothelial cells in a dose-dependent manner. The extract, and especially its mucilage-de…

Pharmacologylcsh:Therapeutics. Pharmacologytransactivationinflammationlcsh:RM1-950Symphytum officinalePharmacology (medical)Comfrey; Endothelial cells; Inflammation; NF-κB; Symphytum officinale; Transactivation; Transcriptiontranscriptioncomfreyendothelial cellsNF-κBOriginal ResearchFrontiers in Pharmacology
researchProduct